-
Something wrong with this record ?
Influence of serum albumin on intracellular delivery of drug-loaded hyaluronan polymeric micelles
K. Nešporová, J. Šógorková, D. Šmejkalová, J. Kulhánek, G. Huerta-Angeles, L. Kubala, V. Velebný,
Language English Country Netherlands
Document type Journal Article
- MeSH
- HT29 Cells MeSH
- HCT116 Cells MeSH
- Intracellular Fluid drug effects metabolism MeSH
- Hyaluronic Acid administration & dosage metabolism MeSH
- Humans MeSH
- Micelles * MeSH
- Drug Carriers administration & dosage metabolism MeSH
- Polymers administration & dosage metabolism MeSH
- Serum Albumin administration & dosage metabolism MeSH
- Drug Delivery Systems methods MeSH
- Protein Binding physiology MeSH
- Cell Survival drug effects physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Polymeric micelles are attractive drug delivery systems for intravenously administered nonpolar drugs. Although physical parameters like size, shape and loading capacity are considered as the most important for their efficiency, here we demonstrate that the effects of serum protein interaction and characteristics of loaded compound cannot be neglected during the micelle development and design of experimental set up. Polymeric micelles prepared from amphiphilic hyaluronic acid grafted with short (hexanoic) and long fatty acids (oleic) were tested after loading with two different hydrophobic models, Nile red and curcumin. The composition of micelles affected mainly the loading capacity. Both encapsulated compounds behaved differently in the in vitro cell uptake, which was also influenced by serum concentration, where serum albumin was found to be the primary destabilizing component. This destabilization was found to be influenced by polymeric micelle concentration. Thus, the chemical structure of micelle, the properties of non-covalently loaded substance and serum albumin/polymeric micelle ratio modulate the in vitro intracellular uptake of drugs loaded in nanocarriers.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023822
- 003
- CZ-PrNML
- 005
- 20170720123150.0
- 007
- ta
- 008
- 170720s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2016.07.057 $2 doi
- 035 __
- $a (PubMed)27473277
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Nešporová, Kristina $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic; Department of Experimental biology, Faculty of Sciences, Masaryk University, Kotlářská 267/2, 611 37 Brno, Czech Republic.
- 245 10
- $a Influence of serum albumin on intracellular delivery of drug-loaded hyaluronan polymeric micelles / $c K. Nešporová, J. Šógorková, D. Šmejkalová, J. Kulhánek, G. Huerta-Angeles, L. Kubala, V. Velebný,
- 520 9_
- $a Polymeric micelles are attractive drug delivery systems for intravenously administered nonpolar drugs. Although physical parameters like size, shape and loading capacity are considered as the most important for their efficiency, here we demonstrate that the effects of serum protein interaction and characteristics of loaded compound cannot be neglected during the micelle development and design of experimental set up. Polymeric micelles prepared from amphiphilic hyaluronic acid grafted with short (hexanoic) and long fatty acids (oleic) were tested after loading with two different hydrophobic models, Nile red and curcumin. The composition of micelles affected mainly the loading capacity. Both encapsulated compounds behaved differently in the in vitro cell uptake, which was also influenced by serum concentration, where serum albumin was found to be the primary destabilizing component. This destabilization was found to be influenced by polymeric micelle concentration. Thus, the chemical structure of micelle, the properties of non-covalently loaded substance and serum albumin/polymeric micelle ratio modulate the in vitro intracellular uptake of drugs loaded in nanocarriers.
- 650 _2
- $a viabilita buněk $x účinky léků $x fyziologie $7 D002470
- 650 _2
- $a nosiče léků $x aplikace a dávkování $x metabolismus $7 D004337
- 650 _2
- $a systémy cílené aplikace léků $x metody $7 D016503
- 650 _2
- $a HCT116 buňky $7 D045325
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kyselina hyaluronová $x aplikace a dávkování $x metabolismus $7 D006820
- 650 _2
- $a intracelulární tekutina $x účinky léků $x metabolismus $7 D007424
- 650 12
- $a micely $7 D008823
- 650 _2
- $a polymery $x aplikace a dávkování $x metabolismus $7 D011108
- 650 _2
- $a vazba proteinů $x fyziologie $7 D011485
- 650 _2
- $a sérový albumin $x aplikace a dávkování $x metabolismus $7 D012709
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šógorková, Jana $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
- 700 1_
- $a Šmejkalová, Daniela $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic. Electronic address: daniela.smejkalova@contipro.com.
- 700 1_
- $a Kulhánek, Jaromír $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
- 700 1_
- $a Huerta-Angeles, Gloria $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
- 700 1_
- $a Kubala, Lukáš $u Department of Experimental biology, Faculty of Sciences, Masaryk University, Kotlářská 267/2, 611 37 Brno, Czech Republic; Institute of Biophysics, Academy of Sciences of the Czech Republic, Královopolská 135, 612 65 Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic.
- 700 1_
- $a Velebný, Vladimír $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 511, č. 1 (2016), s. 638-47
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27473277 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720123643 $b ABA008
- 999 __
- $a ok $b bmc $g 1239503 $s 984735
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 511 $c 1 $d 638-47 $e 20160726 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20170720